Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2005-03-04 Director's Dealing
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2005-03-04 English
PRIMARY DOCUMENT
Director's Dealing
2005-03-04 English
PRIMARY DOCUMENT
Director's Dealing
2005-03-04 English
Regulatory Filings 2005
Regulatory Filings Classification · 95% confidence The document is a detailed comment letter from the SEC staff to Bovie Medical Corporation regarding their Amendment No. 1 to Registration Statement on Form S-3 and related filings, including an amended Annual Report on Form 10-KSB/A for the year ended December 31, 2003, and a Quarterly Report on Form 10-QSB for the period ended September 30, 2004. The letter discusses required revisions and disclosures related to the annual report (10-KSB/A), quarterly report (10-QSB), and registration statement. It references specific SEC rules and filing requirements, and requests clarifications and updates to the company's financial and business disclosures. This type of document is a regulatory review letter and does not itself contain the actual annual report or quarterly report, but comments on them and the registration statement. It is not a report publication announcement since it is lengthy and substantive, but it is not the report itself either. It is best classified as a Regulatory Filing (RNS) because it is a regulatory comment letter related to multiple filings and compliance issues, and does not fit into other categories such as Annual Report (10-K) or Interim Report (IR).
2005-03-04 English
PRIMARY DOCUMENT
Director's Dealing
2005-02-25 English
PRIMARY DOCUMENT
Director's Dealing
2005-02-25 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.